Epidermal growth factor (EGF) prevents androgen deprivation-induced neuroendocrine differentiation in prostate cancer

被引：0
|
作者：
Angulo, JC
Martin-Orozco, RM
Ropero, S
Rodriguez-Ubreva, FJ
Zapata, PD
Ropero, RM
Colomer, R
Lopez, JI
Lopez-Ruiz, P
机构：
来源：
JOURNAL OF UROLOGY | 2003年 / 169卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
335
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [41] Treatment with a form of a soluble Activin receptor type IIB prevents androgen deprivation-induced changes in body composition
    Lachey, Jennifer
    Koncarevic, Alan
    Ucran, Jeffrey
    Pearsall, R.
    Seehra, Jasbir
    CANCER RESEARCH, 2009, 69
  • [42] EFFECT OF EPIDERMAL GROWTH-FACTOR (EGF) ON NEONATAL MOUSE INCISOR DIFFERENTIATION
    TOPHAM, RT
    CHIEGO, DJ
    KLEIN, RM
    ANATOMICAL RECORD, 1987, 218 (01): : A139 - A140
  • [43] Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer
    Morabito, N
    Gaudio, A
    Lasco, A
    Catalano, A
    Atteritano, M
    Trifiletti, A
    Anastasi, G
    Melloni, D
    Frisina, N
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (11) : 1766 - 1770
  • [44] Paxillin Regulates Androgen- and Epidermal Growth Factor-induced MAPK Signaling and Cell Proliferation in Prostate Cancer Cells
    Sen, Aritro
    O'Malley, Katherine
    Wang, Zhou
    Raj, Ganesh V.
    DeFranco, Donald B.
    Hammes, Stephen R.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (37) : 28787 - 28795
  • [45] Alendronate prevents bone loss in men on androgen deprivation therapy for prostate cancer.
    Greenspan, SL
    Wagner, JM
    Nelson, JB
    Resnick, NM
    Parker, RA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S93 - S93
  • [46] Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity following permanent interstitial brachytherapy
    Hinerman-Mulroy, A
    Butler, W
    Merrick, G
    Allen, Z
    Adamovich, E
    MEDICAL PHYSICS, 2004, 31 (06) : 1864 - 1864
  • [47] Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity following permanent interstitial brachytherapy
    Reed, D
    Merrick, G
    Hinerman-Mulroy, A
    Butler, W
    Wallner, K
    Allen, Z
    Adamovich, E
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S127 - S127
  • [48] Large cell differentiation of metastatic prostate cancer after androgen deprivation therapy
    Patel, Rutveej
    Faiena, Izak
    Geltzeiler, Jules
    CANADIAN JOURNAL OF UROLOGY, 2015, 22 (02) : 7752 - 7754
  • [49] Urethral metastasis with neuroendocrine differentiation in a patient with prostate cancer treated with hormone deprivation
    Sabharwal, Karamveer
    Kumar, Anant
    Abrari, Andleeb
    INDIAN JOURNAL OF UROLOGY, 2019, 35 (01) : 75 - 77
  • [50] IMPACT OF ANDROGEN DEPRIVATION ON THE PROGNOSTIC VALUE OF NEUROENDOCRINE DIFFERENTIATION FOR HIGH GRADE PROSTATE CANCERS TREATED WITH RADIOTHERAPY
    Krauss, D.
    Amin, M.
    Hayek, S.
    Ye, H.
    Kestin, L.
    Vicini, F.
    Ghilezan, M.
    Brabbins, D.
    Gustafson, G.
    Martinez, A.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S383 - S383
12345